Germany imported 1,759 kilograms (3,878 kilos) of medical cannabis flower for pharmacy meting out through the third quarter of 2020, new knowledge from the Federal Institute for Drugs and Medical Devices (BfArM) shows.

This represents a 28% lower over the earlier quarter however is 34% decrease than the identical quarter final 12 months.

However, for the January-September interval, imports are up 15% in comparison with the primary 9 months of 2019.

Import knowledge is a related metric for companies concerned within the German medical marijuana market as a result of the flower class is completely depending on imports and – as Marijuana Business Daily first reported – that development will proceed till not less than the tip of the primary quarter of 2021.

Flower gross sales characterize greater than half the German medical marijuana market.

Import portions fluctuate considerably all year long, so they’re arduous to foretell and don’t essentially characterize how home gross sales are evolving – which means drawing conclusions from import knowledge alone ought to be prevented.

Not all imported flower is destined for German customers.

Some may have been destroyed – for instance, if it was not offered earlier than the tip of its shelf-life – or re-exported to different European nations, together with the Czech Republic, Italy, Luxembourg, Malta, Poland and the United Kingdom.

Two necessary indicators of how the market evolves embody:

  • Reimbursement knowledge, which lately dropped for the primary time on a quarterly foundation.
  • How particular person purposes for reimbursement evolve, a state of affairs MJBizDaily lately up to date.

It stays unsure how the 12 months will finish, however the present state of affairs signifies that year-over-year development in 2020 won’t be as spectacular as earlier years.

Since the beginning of the present medical marijuana program in early 2017, the flower market doubled in 2018 and once more in 2019.

MJBizDaily‘s European medical cannabis report, revealed in May, predicted for the 2020 market that:

Slower year-over-year development shouldn’t be stunning. As of press time for this report, the availability state of affairs was fairly good in Germany. The robust development from 2018 to 2019 may very well be partially defined by an undersupplied market in 2018. Keeping the year-over-year development fee in 2020 after a better-supplied market in 2019 can be difficult.

Alfredo Pascual might be reached at [email protected]



Source link